New York Times Op-ed by Board Member Sundas Hashmi
My Brother Died of Brain Cancer. 20 Years Later, I Had It, Too.
I was told it didn’t run in families. Was it just chance?
Understanding the condition and connecting with others with the illness can help you feel empowered on your GBM journey.
GBM is one of the most aggressive cancers and one of the hardest to treat, and as a result survival rates are low, with just a 5% five-year survival rate. Existing treatments are not a cure, but a way to extend life. The current standard of care is unlikely to remove the entire tumor. It might no longer be visible following treatment, yet tiny pieces can remain and for the majority of people the tumor returns. On your GBM journey you should equip yourself with as much knowledge as possible to ensure you are aware of the options available beyond standard treatments.
My Brother Died of Brain Cancer. 20 Years Later, I Had It, Too.
I was told it didn’t run in families. Was it just chance?
We Are Living With Brain Cancer. Here’s How Biden Could Help Us.
Like Beau Biden, we have glioblastoma. It doesn’t get the attention it should.
Margaret writes about her and her husband Glenn’s glioblastoma experience, including becoming activists for better treatment.
Prof. Richard Scolyer is an Australian pathologist who’s bravely sharing his GBM journey
My Brother Died of Brain Cancer. 20 Years Later, I Had It, Too.
I was told it didn’t run in families. Was it just chance?
We Are Living With Brain Cancer. Here’s How Biden Could Help Us.
Like Beau Biden, we have glioblastoma. It doesn’t get the attention it should.
Margaret writes about her and her husband Glenn’s glioblastoma experience, including becoming activists for better treatment.
Prof. Richard Scolyer is an Australian pathologist who’s bravely sharing his GBM journey